
Immix Biopharma Inc is a clinical-stage biopharmaceutical company developing Tissue-Specific Therapeutics in oncology and inflammation. Immix Biopharma Inc is a clinical-stage biopharmaceutical company developing Tissue-Specific Therapeutics in oncology and inflammation.
Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.05 | -3.06748466258 | 1.63 | 1.68 | 1.5061 | 40601 | 1.58616555 | CS |
4 | -0.43 | -21.3930348259 | 2.01 | 2.01 | 1.5061 | 58628 | 1.72717623 | CS |
12 | -0.52 | -24.7619047619 | 2.1 | 2.49 | 1.5061 | 94644 | 2.03650088 | CS |
26 | -0.26 | -14.1304347826 | 1.84 | 2.71 | 1.26 | 134057 | 1.90326916 | CS |
52 | -1.54 | -49.358974359 | 3.12 | 3.3528 | 1.26 | 139487 | 2.11183222 | CS |
156 | -0.32 | -16.8421052632 | 1.9 | 7.75 | 0.68 | 495907 | 2.34485525 | CS |
260 | -3.42 | -68.4 | 5 | 8.6799 | 0.68 | 912789 | 4.0693335 | CS |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales